Shanghai, China

Guirui Yan

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Shanghai Puyou Biomedical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guirui Yan. Retrieved from https://idiyas.com/inventor/guirui-yan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guirui Yan: Innovator in Atherosclerosis Treatment

Introduction

Guirui Yan is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biomedical research, particularly in the prevention and treatment of atherosclerosis and related diseases. His innovative approach has the potential to impact many lives.

Latest Patents

Guirui Yan holds a patent for "Methods and compositions for preventing and treating atherosclerosis and related diseases." This patent describes a method for preventing or treating atherosclerosis in individuals in need. The method involves administering a therapeutically effective amount of sDSS1 protein or its variants, along with other therapeutic strategies.

Career Highlights

Yan is associated with Shanghai Puyou Biomedical Co., Ltd., where he continues to advance his research and development efforts. His work focuses on innovative solutions to combat cardiovascular diseases, showcasing his dedication to improving health outcomes.

Collaborations

Some of his notable coworkers include Yinghao Zhang and Yao Wang. Their collaboration enhances the research environment and fosters innovation within the company.

Conclusion

Guirui Yan's contributions to the field of atherosclerosis treatment exemplify the impact of innovative thinking in biomedical research. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…